Semler Scientific, Inc. Lawsuit Overview
NEW YORK — Levi & Korsinsky, LLP announces important news for investors in Semler Scientific, Inc. (NASDAQ: SMLR). Recently, a class action securities lawsuit has been filed, focusing on potential securities fraud affecting shareholders.
Understanding the Class Action
The class action lawsuit aims to recover losses for investors of Semler Scientific who suffered during a significant time frame affected by alleged securities fraud from March 10, 2021, to April 15, 2025. This lawsuit raises critical concerns around the misrepresentation of facts by the company.
Key Allegations Against Semler Scientific
According to the filed complaint, there are serious allegations concerning the company’s disclosures. It is claimed that Semler failed to inform the public of a substantial investigation conducted by the U.S. Department of Justice regarding breaches of the False Claims Act. Instead, discussions were presented in hypothetical terms, misleading investors about potential violations.
The Impact on Investors
For investors who experienced financial loss during the designated period, this development poses a significant legal opportunity. It's essential to understand the implications of this lawsuit, as the outcome could determine the feasibility of compensating affected shareholders.
Next Steps for Shareholders
If you believe you have incurred losses while holding shares of Semler Scientific, the deadline for requesting to be appointed as lead plaintiff is approaching. You have until October 28, 2025, to step forward. However, it's important to note that participating in any recovery does not obligate you to take on the responsibilities of a lead plaintiff.
Cost-Free Participation
Joining this class action as a member could allow you to receive compensation without any upfront fees or costs. There is no financial obligation to pursue your rights as part of this process.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has built a robust reputation over the past two decades, securing substantial settlements for investors. The firm specializes in handling complex securities cases and boasts a team of over 70 professionals dedicated to representing shareholders whose rights may have been violated.
Contact Information
The firm encourages affected investors to reach out for further information. Joseph E. Levi, Esq. can be contacted by telephone at (212) 363-7500 or via email. This is an opportunity for potential plaintiffs to discuss their situations in detail and understand their rights related to the lawsuit.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit involves allegations of securities fraud against Semler Scientific and seeks to recover losses incurred by shareholders during a specific timeframe.
When is the deadline for investors to act?
Investors have until October 28, 2025, to request to become a lead plaintiff in this case.
What costs are involved in participating in the lawsuit?
There are no costs or fees for class members involved in the lawsuit, allowing participation without any financial risk.
Why is this lawsuit significant for shareholders?
This lawsuit represents an opportunity for shareholders to potentially receive compensation for losses incurred due to misleading statements by the company.
How can I contact Levi & Korsinsky?
Joseph E. Levi, Esq. can be contacted at (212) 363-7500 or via email for further inquiries regarding participation in the lawsuit.
